2009-11-10 11:37:01 -
Nellix Endovascular Inc. - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/nellix-endov ..
Nellix Endovascular Inc. - Medical Equipment - Deals and Alliances Profile
Summary
Nellix Endovascular Inc. (Nellix) is engaged in the manufacturing and distribution of endograft devices. The product portfolio of the company includes aortic endograft device. This device is used in the treatment of Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms. The company is headquartered at Palo Alto in California, the US. Nellix technology can be used for the treatment of all aortic aneurysms and provides different advantages over current therapies and it has the potential to double the number of aneurysms that can be treated with minimally invasive EVAR
The Nellix Endovascular Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The
profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.